§ Funding Round
4D Molecular Therapeutics raised $75M Series C venture round, led by Viking Global Investors.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
Amzak Health | — | — |
| Organization | — | |
| Organization | — | |
BVF Partners | — | — |
| Organization | — | |
| Organization | — | |
Michael Boyle | — | — |
| Organization | — | |
Mirae Asset | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Viking Global InvestorsLEAD | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$168M
Top Valuation
-
4D Molecular Therapeutics raised $75M in a Series C round.
The round was announced on 06/16/20.
The round was led by Viking Global Investors.
